IFNAR1 and cancer: Chen, et al. reported that abolishing type I IFN signaling by knocking out interferon α/β receptor subunit 1 2(IFNAR1) provoked a pronounced immune response after tumor ionizing radiation from four murine cancer cell lines, including mesothelioma.